Results 271 to 280 of about 1,122,477 (316)
Some of the next articles are maybe not open access.

The Epidemiological Evaluation of Drugs

Acta Medica Scandinavica, 1984
ABSTRACT. Depending on the research problem, the epidemiological evaluation of drugs must be based on a combination of research strategies that include experimental methods (controlled trials), and non‐experimental methods. Among the latter are correlational studies; spontaneous reporting systems and published case reports; cohort studies; and case ...
openaire   +3 more sources

Evaluation of the teratogenicity of drugs

Clinical Pharmacology & Therapeutics, 1964
The detection of the teratogenic effect of drugs remains a challenge. The sudden appearance of the problem has baffled pharmacologists. The testing of the teratogenic action of a new drttg requires a systematic and complete investigation, without bias, based on the chemical s1rttctttre or pharmacologic action.
openaire   +3 more sources

Drug safety evaluation of desogestrel

Expert Opinion on Drug Safety, 2013
Desogestrel (DSG) is a third-generation progestin. It is commonly used in various formulations for hormonal contraception including combinations with ethinyl estradiol (EE), progestin-only pill and subdermal implants. DSG is also used in menopausal patients for hormone replacement therapy (HRT).The current manuscript aims to review the available data ...
SCALA, CAROLINA   +4 more
openaire   +5 more sources

Drug Evaluation by Council on Drugs

JAMA: The Journal of the American Medical Association, 1963
WHEN A PHYSICIAN writes a prescription for a completely new drug, it is a moment of great decision. He has had to assess a welter of claims before deciding to use a new drug in preference to one of the older drugs that he knows well. Many hopes rest on that moment.
openaire   +2 more sources

Clinical Evaluation of Drugs

Annual Review of Medicine, 1958
and L Lasagna, P Meier
openaire   +3 more sources

Comparative Evaluation of Drugs

1984
In most countries radiopharmaceutical drugs have now become recognized as substances which require reviewing and acceptance by a governmental agency before the medical profession is allowed their unrestricted use. However many uncertainties still exist about the basis for reviewing.
Rolf de Jong, Wim B. Huising
openaire   +2 more sources

EVALUATION OF NEW DRUGS

Journal of the American Medical Association, 1951
To the Editor: —It is pertinent to keep the published record clear regarding the standards and ideals of scientists and physicians of the United States. Especially is this necessary in matters involving new and allegedly useful methods of handling disease.
openaire   +2 more sources

Drug Evaluation Data

Drug Intelligence & Clinical Pharmacy, 1971
Robert J. Allen   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy